Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    Open Studies | "Papillomavirus Infections"
Show Display Options
Rank Status Study
1 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
2 Recruiting Lubricant Investigation in Men to Inhibit Transmission of HPV Infection
Condition: Human Papillomavirus Infection
Interventions: Other: Carrageenan-based gel;   Other: Control gel
3 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
Conditions: Cancer Survivor;   Prevention of Human Papillomavirus Infection
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58);   Other: laboratory biomarker analysis;   Other: survey administration;   Other: medical chart review
4 Recruiting Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Condition: Human Papillomavirus Infection
Interventions: Biological: HPV vaccine, Gardasil 9;   Biological: Hepatitis A vaccine
5 Recruiting Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
Condition: Human Papilloma Virus Infection
Interventions: Other: First-void urine collection;   Other: Blood draw
6 Recruiting Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort
Condition: Human Papillomavirus-Related Cervical Carcinoma
Intervention: Other: Agreement between oral and cervical HPV infection
7 Not yet recruiting Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
Conditions: Uterine Cervical Dysplasia;   Papillomavirus Infections
Interventions: Drug: AV2;   Drug: Placebo
8 Recruiting Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Conditions: Healthy Subject;   Human Papillomavirus Infection
Interventions: Drug: carrageenan-containing gel;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
9 Recruiting Study of the Prevention of Anal Cancer
Conditions: Human Papillomavirus;   Cancer
Interventions: Procedure: Participants asked questions about recent experiences of anal intercourse in the last six months.;   Procedure: High Resolution Anoscopy
10 Recruiting Community-Driven Cervical Cancer Prevention in Western Kenya
Conditions: Human Papilloma Virus Infection;   Carcinoma in Situ of Uterine Cervix
Interventions: Behavioral: Community-based testing with standard linkage to care;   Behavioral: Community-based HPV testing with enhanced linkage to care
11 Recruiting The Clinical Relevance of P16INK4A Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.
Conditions: Recurrence;   Metastasis;   Death
Intervention:
12 Recruiting Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men
Conditions: HIV Infections;   Papillomavirus Infections;   Anal Intraepithelial Neoplasia
Intervention: Behavioral: Smear and biopsy testing for HPV-types and viral load
13 Recruiting Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Conditions: Anal Carcinoma;   HIV Infection;   Human Papillomavirus Infection
Interventions: Procedure: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
14 Recruiting Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Conditions: Cervical Intraepithelial Neoplasia;   Low-Grade Squamous Intraepithelial Lesions;   Papillomavirus Infections
Interventions: Drug: Aminolaevulinic acid;   Drug: Placebo
15 Recruiting CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Atypical Endocervical Glandular Cell of Undetermined Significance;   Atypical Endometrial Hyperplasia;   Human Papillomavirus Infection;   Stage 0 Cervical Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
16 Recruiting Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: carboplatin;   Radiation: radiation therapy;   Drug: paclitaxel;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
17 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
18 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
19 Not yet recruiting Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
20 Recruiting CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Conditions: Breast Carcinoma;   Cervical Carcinoma;   Colorectal Carcinoma;   Health Status Unknown;   Human Papillomavirus Infection;   Malignant Neoplasm
Intervention: Other: Informational Intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.